Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1932 1
1948 1
1949 1
1950 1
1958 1
1960 2
1962 6
1964 1
1965 2
1966 3
1967 5
1968 4
1969 7
1970 10
1971 12
1972 15
1973 17
1974 7
1975 11
1976 8
1977 24
1978 15
1979 15
1980 13
1981 13
1982 19
1983 25
1984 29
1985 40
1986 42
1987 50
1988 55
1989 74
1990 68
1991 70
1992 83
1993 118
1994 102
1995 147
1996 166
1997 206
1998 258
1999 310
2000 484
2001 469
2002 579
2003 662
2004 849
2005 998
2006 1151
2007 1450
2008 1761
2009 2057
2010 2428
2011 2935
2012 3216
2013 3483
2014 3657
2015 3778
2016 3839
2017 4042
2018 4260
2019 4381
2020 4880
2021 5317
2022 4854
2023 4858
2024 4960
2025 4939
2026 45

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69,772 results

Results by year

Filters applied: . Clear all
Page 1
CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer.
Long SA, Todd H, Goodhart G, Chang WH, Amparo AM, Bridgens R, Dilly J, Park SJ, Beal RM, Shehadeh SM, Satyadi MA, Trivedi VK, Ackermann SE, Mukherjee R, Goodwin CM, Edwards AC, Stalnecker CA, Greis KD, Aguirre AJ, Hobbs GA, Bryant KL, Ahmad SA, Cox AD, Der CJ, Waters AM. Long SA, et al. Among authors: park sj. Cancer Res. 2025 Nov 17. doi: 10.1158/0008-5472.CAN-25-1835. Online ahead of print. Cancer Res. 2025. PMID: 41248420
Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitor.
Bang YH, Park GH, Oh JW, Hwang S, Jeong JG, Lee B, Joe CY, Kim H, Kim J, Park S, Jung HA, Sun JM, Ahn JS, Ahn MJ, Choi YL, Ahn CH, Ali SM, Ock CY, Lee SH. Bang YH, et al. Among authors: park s. J Immunother Cancer. 2025 Oct 31;13(10):e012374. doi: 10.1136/jitc-2025-012374. J Immunother Cancer. 2025. PMID: 41173494 Free PMC article. Clinical Trial.
Plant synthetic biology: from knowledge to biomolecules.
Park S, Mani V, Ha K, Kim JA, Lee S. Park S, et al. Front Plant Sci. 2025 Oct 28;16:1562216. doi: 10.3389/fpls.2025.1562216. eCollection 2025. Front Plant Sci. 2025. PMID: 41230228 Free PMC article. Review.
Neural hijacking in cancer metabolism: from nutrients to organelles.
Shin S, Myoung SY, Cho HJ, Kim S, Lee N, Park SJ. Shin S, et al. Among authors: park sj. Trends Cancer. 2025 Nov 28:S2405-8033(25)00280-8. doi: 10.1016/j.trecan.2025.11.006. Online ahead of print. Trends Cancer. 2025. PMID: 41318256 Free article. Review.
Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women.
Ho PJ, Loo CKY, Lim RJY, Goh MH, Abubakar M, Ahearn TU, Andrulis IL, Antonenkova NN, Aronson KJ, Augustinsson A, Behrens S, Bodelon C, Bogdanova NV, Bolla MK, Brantley KD, Brenner H, Byers H, Camp NJ, Castelao JE, Cessna MH, Chang-Claude J, Chanock SJ, Chenevix-Trench G, Choi JY, Colonna SV, Czene K, Daly MB, Derouane F, Dörk T, Eliassen AH, Engel C, Eriksson M, Evans DG, Fletcher O, Fritschi L, Gago-Dominguez M, Genkinger JM, Geurts-Giele WRR, Glendon G, Hall P, Hamann U, Ho CYS, Ho WK, Hooning MJ, Hoppe R, Howell A, Humphreys K, Ito H, Iwasaki M, Jakubowska A, Jernström H, John EM, Johnson N, Kang D, Kim SW, Kitahara CM, Ko YD, Kraft P, Kwong A, Lambrechts D, Larsson S, Li S, Lindblom A, Linet M, Lissowska J, Lophatananon A, MacInnis RJ, Mannermaa A, Manoukian S, Margolin S, Matsuo K, Michailidou K, Milne RL, Mohd Taib NA, Muir KR, Murphy RA, Newman WG, O'Brien KM, Obi N, Olopade OI, Panayiotidis MI, Park SK, Park-Simon TW, Patel AV, Peterlongo P, Plaseska-Karanfilska D, Pylkäs K, Rashid MU, Rennert G, Rodriguez J, Saloustros E, Sandler DP, Sawyer EJ, Scott CG, Shahi S, Shu XO, Shulman K, Simard J, Southey MC, Stone J, Taylor JA, Teo SH, Teras LR, Terry MB, Torres D, Vach… See abstract for full author list ➔ Ho PJ, et al. Among authors: park sk. Cancers (Basel). 2025 Nov 3;17(21):3561. doi: 10.3390/cancers17213561. Cancers (Basel). 2025. PMID: 41228354 Free PMC article.
[Occurrence of Drowning Accident, 2019-2023].
Park SY. Park SY. Jugan Geongang Gwa Jilbyeong. 2025 Jun 12;18(23):870-873. doi: 10.56786/PHWR.2025.18.23.3. Jugan Geongang Gwa Jilbyeong. 2025. PMID: 41333376 Free PMC article. Korean. No abstract available.
Longitudinal transformation of mitochondrial metabolism during neurogenesis.
Lim D, Park S, Lee JS, Gwon HJ, Nam Y, Choi S, Kim J, Kim Y, Park G, Pyun WY, Park HW, Cho SW, Ahn HS. Lim D, et al. Among authors: park s. Proc Natl Acad Sci U S A. 2025 Nov 25;122(47):e2517961122. doi: 10.1073/pnas.2517961122. Epub 2025 Nov 21. Proc Natl Acad Sci U S A. 2025. PMID: 41269791
Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study.
Massari F, Rosellini M, Melichar B, Grande E, Bourlon MT, Li H, Fiala O, Park SH, Fita MJJ, Taha T, Molina-Cerrillo J, Santini D, de Liañ AG, Büttner T, Scagliarini S, Manneh Kopp R, Zeppellini A, Ghosn M, Conteduca V, Bölek H, Rizzo A, Ansari J, Mollica V, Zgura A, Filosa A, Yildirim A, Akova U, Monteiro FSM, Buti S, Soares A, Bilen MA, Ürün Y, Santoni M. Massari F, et al. Among authors: park sh. JCO Glob Oncol. 2025 Oct;11:e2500376. doi: 10.1200/GO-25-00376. Epub 2025 Oct 29. JCO Glob Oncol. 2025. PMID: 41160781
69,772 results
You have reached the last available page of results. Please see the User Guide for more information.